Fetoscopic Tracheal Balloon Occlusion in Left Diaphragmatic Hernia
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Left diaphragmatic hernia detected during fetal life carries a high risk for postnatal lung failure due to lung underdevelopment and pulmonary hypertension. In severe cases, extracorporeal membrane oxygenation (ECMO) is used as a life-saving intensive care means to enable survival of severely affected infants.
Clinical experience from prospective controlled non-randomized case series with fetoscopic tracheal balloon occlusion has seen improved survival rates in contrast to untreated controls.
Therefore, the purpose of this randomized clinical trial in a less severely affected subgroup of patients is whether by fetoscopic tracheal occlusion, the intensity of postnatal intensive care therapy might be reduced. Primary outcome measure is the need for postnatal ECMO therapy.
| Condition | Intervention | Phase |
|---|---|---|
|
Diaphragmatic Hernia |
Procedure: Fetoscopic tracheal balloon occlusion |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Randomized Clinical Trial in Order to Assess the Effect of Fetoscopic Tracheal Balloon Occlusion on the Postnatal Disease Course in Neonates With Left Congenital Diaphragmatic Hernia - FDH-ECMO/BALLOON-TRIAL |
- Need for postnatal ECMO therapy [ Time Frame: First two days of life ] [ Designated as safety issue: Yes ]
- Survival to discharge from hospital [ Time Frame: Days to discharge ] [ Designated as safety issue: No ]
- Maternal morbidity [ Time Frame: Until maternal discharge ] [ Designated as safety issue: Yes ]
- Fetal / Neonatal morbidity [ Time Frame: Overall & at discharge from hospital ] [ Designated as safety issue: Yes ]
- Premature preterm rupture of membranes [ Time Frame: Following the interventions over the remainder of gestation ] [ Designated as safety issue: Yes ]
- Unintended preterm delivery [ Time Frame: Following the interventions before scheduled elective delivery ] [ Designated as safety issue: Yes ]
- Days in intensive care [ Time Frame: Number of day until discharge from ICU ] [ Designated as safety issue: Yes ]
- Days in hospital [ Time Frame: Number of days until discharge from hospital ] [ Designated as safety issue: Yes ]
- Oxygen dependency on discharge [ Time Frame: Days until discharge ] [ Designated as safety issue: Yes ]
| Estimated Enrollment: | 98 |
| Study Start Date: | January 2009 |
| Estimated Study Completion Date: | July 2014 |
| Estimated Primary Completion Date: | January 2014 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| No Intervention: A |
Procedure: Fetoscopic tracheal balloon occlusion
Maternal local anesthesia, percutaneous ultrasound-guided fetal analgo-sedation and relaxation, percutaneous ultrasound-guided access into amniotic cavity with trocar, fetoscopic tracheal ballon occlusion, removal of fetoscope and trocar, maternal abdominal closure, skin-to-skin time 30 minutes
|
|
Experimental: B
Fetoscopic tracheal occlusion
|
Procedure: Fetoscopic tracheal balloon occlusion
Maternal local anesthesia, percutaneous ultrasound-guided fetal analgo-sedation and relaxation, percutaneous ultrasound-guided access into amniotic cavity with trocar, fetoscopic tracheal ballon occlusion, removal of fetoscope and trocar, maternal abdominal closure, skin-to-skin time 30 minutes
|
Eligibility| Ages Eligible for Study: | 18 Years to 50 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Pregnant women from European countries carrying fetuses with left diaphragmatic hernia.
- Normal karyotype, no further severe anomalies on prenatal ultrasound study.
- Fetal liver herniation into the chest; gestational age-related lung volume between 20-25% of normal as determined by magnetic resonance imaging between 30+0 - 34+0 weeks+days of gestation.
Exclusion Criteria:
- Any maternal disease or condition that would result in an increased risk to her health from the experimental procedure.
- Abnormal fetal karyotype, further severe fetal anomalies on prenatal ultrasound.
Contacts and Locations| Contact: Thomas Kohl, MD | -49-228-2871-5942 | thomas.kohl@ukb.uni-bonn.de |
| Contact: Thomas Schaible, MD | -49-160-550-1023 | t.schaible@t-online.de |
| Germany | |
| German Center for Fetal Surgery & Minimally Invasive Therapy | Recruiting |
| Bonn, Germany, 53105 | |
| Contact: Thomas Kohl, MD 0049-175-597-1213 thomas.kohl@ukb.uni-bonn.de | |
| Contact: Thomas Schaible, MD 0049-160-550-1023 | |
| Principal Investigator: Thomas Kohl, MD | |
| Principal Investigator: Thomas Schaible, MD | |
| Principal Investigator: | Thomas Kohl, MD | German Center for Fetal Surgery & Minimally-Invasive Therapy, University of Bonn, Germany |
| Principal Investigator: | Thomas Schaible, MD | Neonatal Intensive Care Unit (ECMO center), University of Mannheim, Germany |
More Information
Publications:
| Responsible Party: | Thomas Kohl MD, German Center for Fetal Surgery & Minimally-Invasive Therapy |
| ClinicalTrials.gov Identifier: | NCT00373438 History of Changes |
| Other Study ID Numbers: | FDH-ECMO/BALLOON-TRIAL-135/06, 135/06 |
| Study First Received: | September 6, 2006 |
| Last Updated: | January 5, 2009 |
| Health Authority: | Germany: Ethics Commission |
Keywords provided by University Hospital, Bonn:
|
Congenital diaphragmatic hernia tracheal occlusion fetus |
fetal surgery fetoscopy ECMO |
Additional relevant MeSH terms:
|
Hernia Hernia, Diaphragmatic Hernia, Hiatal Pathological Conditions, Anatomical |
ClinicalTrials.gov processed this record on May 19, 2013